Clover Health Investments (NASDAQ:CLOV) VP Joseph Frank Oldakowski Sells 3,170 Shares of Stock

Clover Health Investments, Corp. (NASDAQ:CLOV) VP Joseph Frank Oldakowski sold 3,170 shares of Clover Health Investments stock in a transaction on Wednesday, September 16th. The shares were sold at an average price of $4.64, for a total transaction of $14,708.80. Following the completion of the sale, the vice president directly owned 275,897 shares of the company’s stock, valued at approximately $1,280,162.08. The trade was a 1.14% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Joseph Frank Oldakowski also recently made the following trade(s):

• On Monday, September 14th, Joseph Frank Oldakowski sold 20,000 shares of Clover Health Investments stock. The stock was sold at an average price of $5.16, for a total transaction of $103,200.00.

Clover Health Investments Price Performance

NASDAQ CLOV opened at $4.54 on Friday. Clover Health Investments, Corp. has a fifty-two week low of $1.58 and a fifty-two week high of $5.59. The stock’s 50-day moving average is $4.42 and its two-hundred day moving average is $3.62. The firm has a market cap of $2.41 billion, a P/E ratio of -90.78 and a beta of 2.47.

Clover Health Investments (NASDAQ:CLOV) last issued its quarterly earnings data on Wednesday, August 5th. The company reported $0.05 earnings per share for the quarter, beating analysts’ consensus estimates of $0.04 by $0.01. The business had revenue of $743.17 million for the quarter, compared to the consensus estimate of $728.27 million. Clover Health Investments had a negative return on equity of 4.20% and a negative net margin of 0.74%. On average, equities analysts expect that Clover Health Investments, Corp. will post 0.06 EPS for the current year.

Analysts Set New Price Targets

Several brokerages have recently issued reports on CLOV. UBS Group raised their price target on Clover Health Investments from $4.75 to $5.00 and gave the company a “neutral” rating in a research report on Thursday, August 6th. Zacks Research raised Clover Health Investments to a “hold” rating in a report on Monday. Wall Street Zen downgraded shares of Clover Health Investments from a “strong-buy” rating to a “buy” rating in a research note on Sunday, August 16th. Deutsche Bank Aktiengesellschaft initiated coverage on shares of Clover Health Investments in a research report on Thursday, September 10th. They set a “buy” rating and a $6.00 target price on the stock. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Clover Health Investments in a research report on Wednesday, June 24th. Two analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $4.75.

Institutional Trading of Clover Health Investments

Institutional investors and hedge funds have recently modified their holdings of the company. Bank of New York Mellon Corp acquired a new stake in Clover Health Investments during the second quarter worth $6,346,000. Tidal Investments LLC acquired a new position in shares of Clover Health Investments in the 2nd quarter valued at $2,156,000. WINTON GROUP Ltd bought a new position in shares of Clover Health Investments during the 2nd quarter worth about $913,000. California State Teachers Retirement System boosted its position in shares of Clover Health Investments by 24.1% during the 1st quarter. California State Teachers Retirement System now owns 497,006 shares of the company’s stock valued at $875,000 after acquiring an additional 96,458 shares in the last quarter. Finally, AXQ Capital LP boosted its position in shares of Clover Health Investments by 602.6% during the 2nd quarter. AXQ Capital LP now owns 146,569 shares of the company’s stock valued at $768,000 after acquiring an additional 125,708 shares in the last quarter. 19.77% of the stock is currently owned by institutional investors.

About Clover Health Investments

Clover Health Investments, Inc is a healthcare technology and insurance company focused on providing Medicare Advantage plans to eligible Medicare beneficiaries. Its insurance business offers medical coverage and related healthcare benefits through plans available in select counties across the United States.

The company also develops and uses Clover Assistant, a technology platform designed to support physicians with patient information, clinical insights, care recommendations and tools intended to help improve healthcare outcomes.